To understand the mechanisms underlying anti–PD-1/anti-MIF–induced tumor regression, we first measured representative circulating cytokines and chemokines in plasma collected from YUMMER1.7 tumor–bearing mice prior to and after 2 doses of treatment. This evidence concerns the gene MIF and neoplasm.